Loading...
Although targeting lower oxygenation levels (i.e., conservative oxygen therapy) — compared with targeting higher oxygen levels — benefits some critically ill patients (e.g., adults with COVID-19), the benefit remains uncertain for a general population of critically ill and mechanically ventilated adults (NEJM JW Gen Med Jan 15 2023 and JAMA 2022; 328:1818).
Investigators from the U.K. randomized 16,500 mechanically ventilated adults (median age, 60) from 97 intensive care units (ICUs) to either conservative oxygen therapy (saturation of peripheral oxygen [SpO2] target, 88%–92%) or usual care (no upper-limit target). A third of patients had sepsis, and only 7% had COVID-19. Key results were as follows:
Mean SpO2 in the conservative group was l…